Manufacturer record

Cian Healthcare Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

5 batches manufactured by Cian Healthcare Ltd (Uttarakhand) were declared Not of Standard Quality between June 2020 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

5 records linked to Cian Healthcare Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
5Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jun 2020 to May 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

5
NSQ batches since 2020
5
Products affected
Other
Most common failure
May 2026
Latest alert

Flagged batches per year

2020 · 12021 · 12024 · 22026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Terbutaline Sulphate, Bromhexine HCL, Guaiphenesin & Menthol Syrup AL25061Mfg 2025-06 · Exp 2027-05 ContentOther DTL, Chennai-06State lab May 2026
C Mont LC KID 60 ml[Montelukast and Levocetirizine Dihydrochloride syrup 60 ml ] AL 23206Mfg 2023-11 · Exp 2025-10 The content of Montelukast sodium is not with in the limits of ?Schedule V? of Drugs and Cosmetics Act & Rules thereunder as specified in the Laboratory ProtocolOther DTL ThiruvananthapuramState lab Oct 2024
C Mont LC Kid 60 ml (Montelukast & Leveocetirizine Dihydrochloride syrup) AL 23206Mfg 2023-11 · Exp 2025-10 The content of montelukast is not within the limits of Schedule ?V? of Drugs & Cosmetics Act & RulesOther DTL ThiruvananthapuramState lab Sep 2024
Belitra - 200 (Itraconazole Capsules 200 mg) AC20084Mfg 2020-08 · Exp 2022-07 DissolutionDissolution CDL KolkataCDSCO lab Jun 2021
Pioglitazone & Metformin Hydrochloride (Prolonged Release) Tablets CT9620Mfg 2019-08 · Exp 2022-01 Dissolution of Metformin HydrochlorideDissolution CDL KolkataCDSCO lab Jun 2020

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.